囊性纤维化跨膜传导调节因子治疗中囊性纤维化患者的超低剂量胸部CT与基于模型的迭代重建(MBIR)
前瞻性研究纳入19例成人囊性纤维化患者,在依伐卡托起始后12和24个月行超低剂量胸部CT。24个月时容积超低剂量方案经纯迭代重建(MBIR)辐射剂量低于12个月时七层面方案(0.08±0.01 vs 0.10±0.02 mSv,p=0.02),图像质量可满足诊断,1年与2年平均Bhalla评分无显著变化(p=0.84)。
要点
- 容积超低剂量胸部CT经MBIR重建的辐射剂量为0.08±0.01 mSv,相当于后前位和侧位胸片剂量。
- MBIR图像噪声显著低于混合迭代重建(LD-ASIR)图像(p<0.0001),诊断可接受性及支气管血管结构显示可接受。
- 1年与2年研究间平均Bhalla评分无显著变化(p=0.84)。
核心结论
- 采用纯迭代重建的容积超低剂量胸部CT方案可获得诊断质量的CT图像,被认为对囊性纤维化患者监测极为有用,剂量相当于后前位和侧位胸片。
研究设计与样本
- 前瞻性研究纳入19例成人囊性纤维化患者,在依伐卡托起始后12和24个月行低剂量胸部CT。
- 12个月研究使用既往验证的七层面低剂量轴位CT方案。
- 24个月研究开发容积低剂量胸部CT方案,并分别以混合迭代重建(LD-ASIR)和纯迭代重建(基于模型的迭代重建[LD-MBIR])重建。
- 记录每次扫描的辐射剂量,定量和定性评估图像质量,采用改良Bhalla评分评估疾病严重程度,p<0.05为有统计学意义。
诊断标准与关键数值
- 容积LD-MBIR扫描辐射剂量为0.08±0.01 mSv,低于七层面研究的0.10±0.02 mSv(p=0.02)。
- LD-MBIR和七层面ASIR图像的图像噪声显著低于LD-ASIR图像(p<0.0001)。
- 轴位和冠状位LD-MBIR图像的诊断可接受性评分及支气管血管结构显示可接受。
- LD-MBIR图像在所有评估的定性参数上均优于LD-ASIR图像(p<0.0001)。
- 1年与2年研究间平均Bhalla评分无显著变化(p=0.84)。
临床应用与阅片要点
- 容积超低剂量胸部CT经纯迭代重建(MBIR)可获得诊断质量图像,辐射剂量相当于后前位和侧位胸片,原文认为对囊性纤维化患者监测极为有用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To assess the utility of a volumetric low-dose computed tomography (CT) thorax (LDCTT) protocol at a dose equivalent to a posteroanterior (PA) and lateral chest radiograph for surveillance of cystic fibrosis (CF) patients.
MATERIALS AND METHODS: A prospective study was undertaken of 19 adult patients with CF that proceeded to LDCTT at 12 and 24 months following initiation of ivacaftor. A previously validated seven-section, low-dose axial CT protocol was used for the 12-month study. A volumetric LDCTT protocol was developed for the 24-month study and reconstructed with hybrid iterative reconstruction (LD-ASIR) and pure iterative reconstruction (model-based IR [LD-MBIR]). Radiation dose was recorded for each scan. Image quality was assessed quantitatively and qualitatively, and disease severity was assessed using a modified Bhalla score. Statistical analysis was performed and p-values of <0.05 were considered statistically significant.
RESULTS: Volumetric LD-MBIR studies were acquired at a lower radiation dose than the seven-section studies (0.08 ± 0.01 versus 0.10 ± 0.02 mSv; p=0.02). LD-MBIR and seven-section ASIR images had significantly lower levels of image noise compared with LD-ASIR images (p<0.0001). Diagnostic acceptability scores and depiction of bronchovascular structures were found to be acceptable for axial and coronal LD-MBIR images. LD-MBIR images were superior to LD-ASIR images for all qualitative parameters assessed (p<0.0001). No significant change was observed in mean Bhalla score between 1-year and 2-year studies (p=0.84).
CONCLUSIONS: The use of a volumetric LDCTT protocol (reconstructed with pure IR) enabled acquisition of diagnostic quality CT images, which were considered extremely useful for surveillance of CF patients, at a dose equivalent to a PA and lateral chest radiograph.
引用
- Moloney F, Kavanagh RG, Ronan NJ, et al. Ultra-low-dose thoracic CT with model-based iterative reconstruction (MBIR) in cystic fibrosis patients undergoing treatment with cystic fibrosis transmembrane conductance regulators (CFTR). Clin Radiol. 2021. PMID: 33468311. doi:10.1016/j.crad.2020.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。